Gastroenterology and Digestive Disorders Conference

Dialysis and COVID-19

COVID-19, a disease affected by a novel corona virus (SARS CoV-2) is currently a pandemic, which produces high morbidity in the elderly and in patients with allied comorbidities. A small proportion of patients (nearly 5%) of COVID – 19 develop AKI. The disease is usually mild but a small number may require Renal Replacement Therapy. In addition, even smaller proportion of patients with secondary bacterial infection will have septic shock, drug nephrotoxicity or fading of existing CKD severe enough to need Renal Replacement Therapy. Patients who are already receiving peritoneal dialysis (PD) treatment have the relative advantage over patients who are receiving hospital or satellite-based haemodialysis treatment as they will not be exposed to hospital environment.

Nephrology Conferences | Nephrology Webinars 2020 | Euro Nephrology Online Events | Nephrology Conference Online Webinar  | Dialysis Conferences | Scientific Webinars on Nephrology and Urology | Renal Conferences | Clinical Nephrology Conferences | Kidney Transplant Conferences | Urology Conferences | Best Chemistry Podcasts 2020 | Nephrology Conferences 2020 Europe | Kidney Disease Conferences | Nephrology Webcast | Chronic Kidney Disease Conferences | Renal Failure Conferences | Nephritis Meetings